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Immunogenicity induced by recombinant plasmids based on the BAB1_0267 and
BAB1_0270 open reading frames (ORFs) of Brucella abortus 2308 was evaluated.
Bioinformatics analyses indicate that the BAB1_0267 and BAB1_0270 ORFs encode
a protein with a SH3 domain and a Zn-dependent metalloproteinase, respectively. Both
ORFs have important effects on intracellular survival and replication of B. abortus 2308,
mediated via professional and non-professional phagocytic cells. Our results show that
immunization with the recombinant plasmid based on the BAB1_0267 ORF significantly
increases the production of IgG1, levels of IFN-γ and the lymphoproliferative response of
splenocytes. However, BAB1_0267 did not provide significant levels of protection. The
plasmid based on the BAB1_0270 significantly increased IgG2a production, levels of
IFN-γ and TNF-α, and the lymphoproliferative response of splenocytes. These results
demonstrate that immunization with the BAB1_0270 derived recombinant plasmid
induce a Th1-type immune response, correlated with a heightened resistance to
B. abortus 2308 infection in mice. It is concluded that the Th1-type immune response
against bacterial Zn-dependent metalloproteinase induces a protective response in mice,
and that pV270 recombinant plasmid is an effective candidate microbicide against
brucellosis.
Keywords: brucellosis, DNA vaccines, zinc-dependent metalloproteinase, Src homology 3 domain, interferon
gamma
INTRODUCTION
Brucellosis, caused by Brucella spp., a Gram-negative coccobacillus, is a zoonosis of worldwide
occurrence. This disease is associated with high morbidity in animals and humans, leading to
important economic losses and public health problems in many countries (Seleem et al., 2010).
Each Brucella species has a high degree of host specificity, but most can infect humans; B. melitensis,
B. abortus, and B. suis being the most pathogenic (He, 2012). B. abortus infects mainly bovines of
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reproductive age, causing abortion, and infertility. In humans,
the infection is characterized by undulant fever during its acute
phase and localization of the pathogen in several organs during its
chronic phase and, if not treated, it can become an invalidating or
even fatal disease (Franco et al., 2007; Seleem et al., 2010).
The chronicity of brucellosis is related to the intracellular
facultative lifestyle of Brucella organisms, which are able to
live in different cell types, including macrophages and dendritic
cells. It has been demonstrated that B. abortus, after entering
a cell, avoids the last step of the phagolysosome pathway
(i.e., fusion with a lysosome) by residing within a unique
organelle, the Brucella-containing vacuole, that is derived from
the endoplasmic reticulum. After maturation, assisted by the
VirB Type IV secretion system of Brucella, the vacuole becomes
permissive of replication (Comerci et al., 2001). In addition,
the mature vacuole strategically modulates specific aspects of
the immune response, making the host tolerant and therefore
achieving the chronicity of the disease (Martirosyan et al., 2011).
Brucella spp. also do not produce classical virulence factors,
such as capsules, exotoxins, secreted proteases, fimbriae, phage
encoded toxins, or virulence plasmids, which contributes to their
adaptive success (Lamontagne et al., 2010).
Open reading frames (ORFs), present within genomic islands
(GIs), are known to encode several virulence factors in
brucellosis. In particular, some GI3 ORFs are important to
B. abortus 2308 virulence (Céspedes et al., 2012; Salcedo et al.,
2013). Inducedmutations in theGI3 BAB1_0267 and BAB1_0270
ORFs of B. abortus 2308 have indicated their role in intracellular
survival and replication of this pathogen in professional and non-
professional phagocytes (Ortiz-Román et al., 2014). Furthermore,
bioinformatics information indicates that BAB1_0267 codifies a
protein with a Src homology 3 (SH3) domain. These domains
are present in a wide variety of intracellular and membrane
proteins (Bakal andDavies, 2000). It has been postulated that SH3
domains promote bacterial survival intracellularly bymodulating
SH3 domain associated signaling pathways of the eukaryotic
cell and/or promoting invasion by binding to receptors present
on the host cell (Whisstock and Lesk, 1999; Bakal and Davies,
2000). This latter function has been described by Bougneres
(Bougneres et al., 2004), who demonstrated that Shigella invades
eukaryotic cells by means of SH3 domains. BAB1_0270 ORF
encodes a Zn-dependent metalloproteinase, a member of the
widely distributed Zn-metallopeptidase family in bacteria. This
protein serves as virulence factor in many pathogens (Barrett
et al., 2004; Bonis et al., 2010; Cafardi et al., 2013; Menon
and Govindarajan, 2013). Some bacteria like Mycobacterium
tuberculosis express Zn-metallopeptidases for immune evasion
purposes, while Helicobacter pylori use them for colonization
and acquire morphological changes (Master et al., 2008; Bonis
et al., 2010). Given that proteins with SH3 domains and
Zn-metalloproteases are important for bacterial virulence, we
hypothesize that B. abortus 2308 BAB1_267 and BAB1_0270
ORFs are potential candidates for developing new vaccines
against Brucellosis.
To prevent bovine brucellosis, immunization with the vaccinal
B. abortusRB51 andB. abortus S19 strains has been implemented.
Although, both vaccines have been effective they cannot
eradicate the pathogen and they are pathogenic for humans
(Schurig et al., 2002). It is therefore necessary to develop an
effective and safe vaccine able to trigger host immunity against
B. abortus. A DNA vaccine that safely expresses immunogens
protecting against Brucella infection could be more effective
for controlling brucellosis. Immunization with DNA vaccines
activates cell-mediated immunity (Shedlock and Weiner, 2000).
The infectious agents are eliminated by high levels of IFN-
γ and TNF-α, produced by activated Th1 CD4+ lymphocytes
(Golding et al., 2001). Among the cytokines secreted, IFN-γ
is pivotal in the clearance of intracellular pathogens and thus
is required to eliminate B. abortus (Murphy et al., 2001). The
aim of this study is to use B. abortus 2308 BAB1_0267 and
BAB1_0270 ORFs to construct DNA vaccines and to evaluate
their effect on the immune response in a BALB/c mouse
model.
MATERIALS AND METHODS
Animals
Ten-week old female isogenic BALB/c mice were obtained
from the Instituto de Salud Pública (Santiago, Chile). The
animals were kept at the Laboratory of Molecular Immunology
(Department of Microbiology, Faculty of Biological Sciences,
Universidad de Concepción, Chile) and after arrival were
randomly distributed into experimental and control groups and
acclimated. The mice were kept under controlled temperature
and fed with commercial pellets and water ad libitum. All
regulations from the Institutional Bioethics Committee of the
Faculty of Biological Sciences, Universidad de Concepción,
were fulfilled. The Bioethics and Security committee of the
Faculty of Biological Sciences in the Universidad de Concepción
approved this study. All efforts were made to minimize animal
suffering.
Construction of Recombinant Plasmids
Vaccines were constructed by cloning the B. abortus BAB1_0267
and BAB1_0270 ORFs into the pVAX1 vector (Invitrogen).
To achieve this, the ORFs were amplified by means of the
polymerase chain reaction (PCR) using primers design in
accordance with the appropriate sequences available at GenBank
(CAJ10223.1 and CAJ10226). The final primer sequences,
including the cutting sites for BamHI and XhoI, were:
BAB1_0267 forward: 5′GCCGGATCCGCCACCATGTTGTCG
AAGGCGAAAAACTGG3′ and reverse: 5′TTTCTCGAGCTAA
ACCACCCAGAGCGGT3′. The final sequence to BAB1_0270
was forward: 5′-GCCGGATCCGCCACCATGAGCAGTCAGA
ATTACGTTGTC-3′, and reverse: 5′-GCCCTCGAGTCAGATC
CCTTTTTTATTGATCCA-3′. PCR product was cloned into the
pVAX1 vector using T4 DNA ligase (Promega, Madison, WI).
The resulting constructs were named pV267 and pV270, and
used for DNA immunization. To obtain the quantity of DNA
required for all immunizations, E. coli DH5α strain (Thermo
Fisher Scientific Inc., MA) was transformed by electroporation
with the constructs and recombinant plasmid DNA was isolated
using the EndoFree Plasmid Giga kit (Qiagen, Valencia, CA).
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Immunization of Mice
Mice received, intramuscularly, 100 µg of the pV267 or pV270
constructs (DNA vaccines) in 100 µl of phosphate buffer saline
(PBS), divided into two injections of 50 µl in each posterior
tibialis muscle. Control groups received either 100 µg pVAX1
in 100 µl of PBS or 100 µl of PBS, injected as described above
for the experimental group (Dhama et al., 2008). All groups were
immunized three times at 15-day intervals.
Purification of the Protein Codified by
pV267 and pV270
The proteins codified by the BAB1_0267 and BAB1_0270 ORFs
were required to evaluate humoral and cellular adaptive immune
responses in experimental and control mice. Bioinformatics
analyses indicate that the product of BAB1_0267 includes 117
amino-acids (aa) has a molecular weight (MW) of ∼13 kDa,
and includes a Src homology 3 (SH3) domain, while the product
of BAB1_0270 is a protein of 182 aa with a MW of 22
kDa, corresponding to a Zn-dependent metalloproteinase. These
recombinant proteins were expressed in E. coli BL21 (DE3) strain
and purified by Novoprotein Scientific Inc. (Summit, NJ., USA)
and will be hereon named SH3-267 and ZM270, respectively
(Figure 1).
Production of Immunoglobulins
The antibody isotypes IgG, IgG1, and IgG2a titers were
measured from peripheral blood using an indirect Enzyme-
Linked Immunosorbent Assay (ELISA). Serum was collected
at days 0, 15, 30 and 45 post-immunization. Ninety-six-well
polystyrene microtiter plates (Thermo Fisher Scientific Inc., MA)
were coated with 1 µg/ml recombinant SH3-267 or ZM270
proteins in 0.05 M carbonate-bicarbonate buffer (pH 9.6) and
left overnight at 4◦C in a humid chamber. After washing the
plates with PBS-0.05% Tween-20 (v/v) buffer, they were treated
FIGURE 1 | Electrophoresis of SH3-267 (A) and ZM270 (B) recombinant
proteins using 12% sodium dodecyl sulfate polyacrylamide gel
(SDS-PAGE). Lane 1: molecular weight marker (kDa), lane 2: recombinant
proteins.
with 0.8% gelatin (w/v) in PBS-Tween-20 buffer for 1 h at 37◦C
in order to block non-specific sites. Serial two-fold dilutions
of sera containing primary antibodies from test and control
animals were added and incubated for 3 h at room temperature.
Rabbit anti-mouse IgG, IgG1, and IgG2a secondary antibodies
conjugated with horseradish peroxidase (US Biological, Life
Sciences) at a dilution of 1:1000, were added and incubated for 45
min. The reaction was revealed using OPD peroxidase substrate
(Sigma-Aldrich Co., MO) and stopped with 50 µl H2SO4 2N.
Results were read using a VictorX3 ELISA reader (PerkinElmer
Chile LTDA, Santiago, Chile) at 490 nm. All assays were done in
triplicate.
Levels of Cytokines
To determine the levels of IFN-γ, TNF-α, and IL-4 secreted, it
was necessary to prepare cell suspensions from the spleens of
experimental and control mice. Briefly, spleens were aseptically
removed from mice, disaggregated, re-suspended in Red Blood
Cell buffer (Promega, Madison, WI) to eliminate erythrocytes
and washed three times using incomplete RPMI 1640 (Thermo
Fisher Scientific, MA). Cells were adjusted to a concentration of
4 × 106 viable cells per ml in RPMI 1640 medium supplemented
with 10% fetal calf serum (Thermo Fisher Scientific, MA) and
antibiotic antimycotic solution (100 UI penicillin, 100 µg/ml
streptomycin and 0.25 µg/ml amphotericin B). Cell suspensions
were cultured in 24-well plates (Nunc, Denmark) containing
0.8 or 4 µg/ml SH3-267 or ZM270 recombinant proteins and
incubated for 72 h at 37◦C and 5% CO2 to stimulate, in vitro,
the expression of cytokines. After centrifuging the plates at
400 × g for 10 min, supernatants were collected and cytokines
quantified by ELISA sandwich using the Mouse IFN-γ, TNF-α,
and IL-4 ELISA kits (eBioscience, San Diego, CA) following
the manufacturer’s instructions. All assays were performed in
triplicate.
Lymphoproliferation Assay
The lymphoproliferative response to the recombinants SH3-
267 and ZM270 proteins was evaluated 30 days after the last
immunization. Spleens were removed from experimental and
control animals and cell suspensions obtained as described above.
Cells were adjusted to a concentration of 4 × 106 viable cells/ml
and cultured (100 µl per well) in 96-well microtiter plates
(Nunc, Denmark), previously sensitized with 0.8 or 4 µg/ml
of recombinants proteins or 1.2 or 6 µg/ml B. abortus 2308
total proteins (Connolly et al., 2006), and incubated for 72 h
at 37◦C and 5% CO2. After 72 h of incubation, 0.5 µCi/well
of thymidine [methyl 3H] (20 Ci/mmol; PerkinElmer, MA) was
added and 8 h later the samples were placed in vials containing
5ml of scintillating solution and cells were harvested using filter
glass paper (Sigma-Aldrish Co. MO). 3H thymidine incorporated
was measured using a Beckman LS 6500 Scintillation Counter
(Beckman Coulter Inc., CA). Concanavalin A (ConA) (Sigma-
Aldrich, MO) at a concentration of 10 µg/ml was used as
proliferative positive control and RPMI 1640 supplemented was
used as proliferative negative control. Values of negative control
were subtracted from the value of all other groups. All assays were
done in triplicate.
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Protection Experiment
For this assay, mice immunized as described above were
challenged, by intraperitoneal injection, with B. abortus 2308 at
a dose of 104 colony-forming units (CFU) per animal. The RB51
strain commercial vaccine, at a dose of 1 × 108 CFU per mouse,
was used as a control (Oñate et al., 2003). After 15 days, all
animals were euthanized and their spleens removed. Spleens were
homogenized in PBS, serially diluted and cultured in Petri dishes
containing agar Columbia supplemented with 5% sheep blood
(bioMérieux, Santiago, Chile) for 72 h at 37◦C. Bacterial counts
were recorded and the number of CFU per spleen calculated.
Results are reported as units of protection represented by the
difference between mean ± SD of log10 CFU/spleen of the PBS
control group with respect to mean ± SD of log10 CFU/spleen
values of experimental groups.
Statistical Analysis
The immune response in mice was analyzed using a two-way
analysis of variance (ANOVA) and the protective response using
a one-way ANOVA. Bonferroni post-test was used to counteract
the problem of multiple comparisons. Data were analyzed using
Prism 5.0 (GraphPad software). Differences were considered
significant if P < 0.05.
RESULTS
Production of Immunoglobulins
Mice immunized with the pV267 recombinant plasmid had
significantly increased titer of IgG at day 30 and 45 post-
immunization when were compared to pVAX and PBS control
groups (Figure 2A). Furthermore, IgG1 production significantly
increased at day 45 post-immunization (P < 0.001; Figure 2B),
while the IgG2 titer did not alter (Figure 2C). Immunization
of mice with the pV270 DNA recombinant plasmid induced
raised levels of IgG in all sampled days (P < 0.01; Figure 2A).
No increment was observed in IgG1 production (Figure 2B),
whereas significant increases in titer of IgG2 occurred on day 30
and 45 post-immunization (P < 0.001; Figure 2C).
Cytokine Levels
The results demonstrate a significant increase of IFN-γ
(P < 0.05) in splenocytes obtained from pV267-immunized
animals, following their exposure to only 4 µg/ml of SH3-267
recombinant protein (Figure 3A). However, none of the two
concentrations (0.8 or 4 µg/ml) increased TNF α levels
(Figure 3B). In vitro stimulation of splenocytes obtained from
pV270-immunized animals incubated with all concentrations
of ZM270 induced a significant increase of IFN-γ (P < 0.001;
Figure 3A) and TNF-α (P< 0.05; Figure 3B), not seen in control
animals. IL-4 expression (P > 0.05) was not affected by any of
the SH3-267 or ZM270 recombinant protein concentrations used
(0.8 or 4 µg/ml) in animals immunized with the pV267 or pV270
recombinant vectors (Figure 3C).
Lymphoproliferative Response
Proliferation of splenocytes from mice immunized with pV267
DNA vaccine increased significantly after stimulation of
FIGURE 2 | Serum IgG (A), IgG1 (B), and IgG2a (C) titers measured by
ELISA at day 0, 15, 30, and 45 post-immunization (n = 5). Results were
expressed as mean ± standard deviation (SD) of the last serum dilution
yielding a specific optical density higher than the cutoff value. **P < 0.01 and
***P < 0.001.
splenocytes with 0.8 or 4 µg/ml SH3-267 recombinant protein
(P < 0.001; Figure 4A). When splenocytes were stimulated in
vitro with 1.2 or 6 µg/ml B. abortus 2308 total proteins, cellular
proliferation increased significantly (P < 0.001 and P < 0.01,
respectively; Figure 4B). In vitro stimulation of splenocytes
from mice immunized with the pV270 DNA vaccine with 0.8
and 4 µg/ml ZM270 recombinant protein product, codified
by BAB1_0270 ORF, and 1.2 or 6 µg/ml total proteins of
B. abortus 2308 also caused increased proliferation of splenocytes
(P < 0.001; Figures 4A,B). This assay used 10 µg/ml of ConA
as positive control, and showed a higher lymphoproliferative
response than all experimental groups (data not shown).
Levels of Protection
The protective capacity provided by the pV267 and pV270 DNA
vaccines was evaluated by challenging mice immunized with
these vaccines with 104 CFU of pathogenic B. abortus strain 2308.
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FIGURE 3 | Expression of IFN-γ (A), TNF-α (B), and IL-4 (C) by spleen
cell cultures from mice stimulated with 0.8 and 4 µg/ml of recombinant
SH3-267 and ZM270 proteins. Results were expressed as mean ± SD
(n = 5). *P < 0.05 and ***P < 0.001.
Results showed that the pV267 DNA vaccine confers protection
against the pathogenic agent, as shown by an increase of 0.63
log10 units of protection (P > 0.05), while immunization with
pV270 DNA vaccine afforded 0.91 log10 units of protection
(P < 0.05; Table 1). The vaccinal RB51 strain produced a
significant increment of 1.8 log10 units of protection compared
to control animals (P < 0.001).
DISCUSSION
Since vaccines so far developed to prevent brucellosis are
not safe, we evaluated the immunogenicity of recombinant
plasmids based on B. abortus BAB1_267 and BAB1_0270
ORFs, encoding of a protein with SH3 domain and a Zn-
dependent metalloproteinase, respectively, in the search for
an effective strategy to prevent this disease. We opted for a
DNA immunization strategy because B. abortus is a facultative
intracellular coccobacilli and recombinant plasmid are able
to induce strong cell-mediated immunity (CMI), a response
dependent on Th1 CD4+ lymphocytes that express INF-γ,
a cytokine pivotal to eliminate this pathogen (Shedlock and
Weiner, 2000; Golding et al., 2001).
The observed patterns of serum immunoglobulins and
cytokinesmeasured frommice immunized demonstrated that the
pV267 recombinant plasmid induced a weak Th1-type immune
response, including low levels of IFN-γ and no observed TNF-α
(Figures 3A,B), but significant production of IgG1, consist
with a Th2-type immune response (Figure 2B; Jankovic and
Feng, 2015). Contrastingly, mice immunized with the pV270
recombinant plasmid increasing the titers of IgG2a isotype
(Figure 2C), produced by plasma cells in the presence of IFN-γ
cytokine (Golding et al., 2001). This response was found to
correlate with significant levels of IFN-γ (Figure 3A) and with
increased TNF-α production (Figure 3B). Importantly, IFN-γ
and TNF-α are associated with effective clearance of intracellular
pathogens, demonstrating that immunization with the pV270
recombinant plasmid induced a polarized Th1-type immune
response (Golding et al., 2001; Murphy et al., 2001). Humoral
immune response induced by the immunization with pV267 or
pV270 were correlated with the significant increase of cellular
immune response, measured by the lymphoproliferative response
of splenocytes after their in vitro stimulation with recombinant
antigens (SH3-267 or ZM270) and B. abortus 2308 total
proteins (Figures 4A,B). Furthermore, the lymphoproliferative
assay confirmed the in vivo expression of the antigen codified by
ORFs of B. abortus 2308, suggesting that both proteins would be
expressed by the pathogen, probably as virulence factors allowing
intracellular survival and replication (Ortiz-Román et al., 2014).
The capacity of the immunogenicity induced for recombinant
plasmids based on the BAB1_0267 and BAB1_0270 ORFs
on protective immunity was evaluated challenging immunized
mice with the pathogenic B. abortus 2308 strain. Our results
confirmed that immunization with pV267 recombinant plasmid
induced a weak immunogenicity associated with no significant
protection conferred to pV267 immunized mice (Table 1). In
eukaryotes, proteins possessing a SH3 domain use this to bind
proteins involved in intracellular signaling to facilitate signal
transduction, and some can regulate Th2-type immune responses
(McCoy et al., 2010). It is possible that the non-significant
protection and low production of IFN-γ by this recombinant
plasmid is the consequence of the Th2-type response by
expression of SH3 domain protein of B. abortus in mice. These
results demonstrate that IFN-γ production by Th1 subset of
CD4 lymphocytes is critical for B. abortus clearance (Golding
et al., 2001; Murphy et al., 2001). By contrast, immunization
with the pV270 DNA recombinant plasmid induced a significant
increase of the levels of protection against B. abortus 2308 strain,
indicating that a polarized pro-inflammatory Th1-type immune
response directed against the Zn-dependent metalloproteinase is
effective in eliminate B. abortus 2308 in a mice model (Table 1).
Therefore, considering that Zn-dependentmetalloproteinases are
used as virulence factors by many pathogens important in public
health (Barrett et al., 2004; Bonis et al., 2010; Cafardi et al.,
2013; Menon and Govindarajan, 2013), and given their role in
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FIGURE 4 | Lymphocyte proliferation after in vitro stimulation with (A) 0.8 or 4 µg/ml recombinant proteins and (B) 1.2 or 6 µg/ml B. abortus 2308 total
proteins. Results are shown as mean ± SD of 3H-thymidine incorporation from mice splenocytes (n = 5). **P < 0.01 and ***P < 0.001.
TABLE 1 | Protection conferred to BALB/c mice immunized with the pV267
and pV270 DNA vaccines when challenged with the pathogenic B. abortus
2308 strain.
Experimental group
(n = 5)
Log10 CFU of Brucella
abortus 2308 per spleen
(means ± SD)
Log10 units
of
protectiona
PBS 5.88 ± 0.06 0
pVAX1 5.88 ± 0.18 0
pV267 5.25 ± 0.15 0.63
pV270 4.97 ± 0.26 0.91*
RB51 vaccinal strain 4.01 ± 0.21 1.8***
aunits of protection represent the difference between log10 CFU values of the PBS control
group and the log10 CFU values of the immunized group. All animals were challenged
with B. abortus 2308 and bacterial counts were assessed at day 15. *P < 0.05 and
***P < 0.001.
intracellular survival and replication of B. abortus BAB1_0270
ORF (Bakal and Davies, 2000), we consider Zn-dependent
metalloproteinases of B. abortus 2308 to be are good target for
vaccine design.
CONCLUSION
In summary this study shows that using a DNA vaccine codifying
a Zn-dependent metalloproteinase is an effective and safe
alternative for expressing protecting antigens in BALB/c mice.
The vaccine induces a Th1-type polarized immune response
and hence protective immunity. The pV270 DNA vaccine
is immunogenic and is able to induce a polarized Th1-type
response, providing significant levels of protection. It is therefore
concluded that this vaccinal candidate is able to induce effective
protection against Brucellosis.
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